![](/img/cover-not-exists.png)
Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma
T. Olencki, D. Peereboom, L. Wood, G. T. Budd, A. Novick, J. Finke, D. McLain, P. Elson, R. M. BukowskiVolume:
127
Language:
english
Pages:
6
DOI:
10.1007/s004320000211
Date:
April, 2001
File:
PDF, 103 KB
english, 2001